Filed Pursuant to Rule 433
Registration Statement 333-141729
900,000,000
4.750% Notes Due 2014
Pfizer Inc.
December 6, 2007
Pricing Term Sheet
|
|
|
Issuer:
|
|
Pfizer Inc. |
Size:
|
|
900,000,000 |
Maturity:
|
|
December 15, 2014 |
Coupon:
|
|
4.750% annually, accruing from December 13, 2007 |
Price to Public
|
|
99.871% of principal amount |
Interest Payment
Dates:
|
|
December 15, commencing on December 15, 2008 |
Optional Redemption:
|
|
At any time for an amount equal to the principal amount of the notes
redeemed plus a make-whole premium and accrued but unpaid interest
to the redemption date |
Make-Whole Premium:
|
|
Bund, flat |
Denominations:
|
|
Minimum of 50,000 principal amount and integral multiples of 50,000 |
Settlement Date:
|
|
December 13, 2007 |
The issuer has filed a registration statement (including a prospectus) with the SEC for the
offering to which this communication relates. Before you invest, you should read the prospectus in
that registration statement and other documents the issuer has filed with the SEC for more complete
information about the issuer and this offering. You may get these documents for free by visiting
EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer
participating in the offering will arrange to send you the prospectus if you request it by calling
Barclays Capital collect at +44 20 7773 9098 or JPMorgan collect at +44 20 7779 2468.
This pricing term sheet supplements the preliminary form of prospectus supplement issued by Pfizer
Inc. on December 6, 2007 relating to its Prospectus dated March 30, 2007.